MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Clinical trial NCT02592577 · COMPLETED

Trial details

NCT number: NCT02592577
Sponsor: Adaptimmune
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Carcinoma

Start date: 2015-11-01
Primary completion: 2020-03-11
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.